FIELD: biotechnologies.
SUBSTANCE: vaccine strain for influenza virus A/17/mallard/Netherlands/00/95(H7N3) is proposed. Strain A/17/mallard/Netherlands/00/95(H7N3) is harmless for laboratory animals. Strain A/17/mallard/Netherlands/00/95(H7M3) has antigenic actuality and attenuation thus meeting the requirements to vaccine strains included in influenza live vaccine, and may be used for production of influenza live and inactivated intranasal vaccine in health care service for influenza prevention.
EFFECT: temperature sensitivity and high degree of cold adaptability.
7 tbl, 3 ex
Authors
Dates
2014-02-20—Published
2012-03-07—Filed